# Precision Antithrombotic Therapy

> **NCT07654634** · — · ENROLLING_BY_INVITATION · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 5000 (estimated)

## Conditions studied

- Non-valvular Atrial Fibrillation (NVAF)
- Venous Thromboembolism (VTE)
- MI(Myocardial Infarction)
- Ischemic Stroke

## Interventions

- **OTHER:** Not applicable- observational study

## Key facts

- **NCT ID:** NCT07654634
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-06-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07654634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07654634, "Precision Antithrombotic Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07654634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*